Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F J Neumann

Showing results (131-140 of 136) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 136 results.
Journal of the American College of Cardiology|June 23, 2001
Long-term mortality benefit with abciximab in patients undergoing percutaneous coronary interventionK M Anderson, R M Califf, G W Stone, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 14, 1997
Dysregulation of monocytic nuclear factor-kappa B by oxidized low-density lipoproteinK Brand, T Eisele, U Kreusel, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|July 16, 2008
Long term outcome after balloon angioplasty and stenting of subclavian artery obstruction: a single centre experienceS Sixt, A Rastan, U Schwarzwälder, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|August 26, 2010
Acute and long-term outcome of Silverhawk assisted atherectomy for femoro-popliteal lesions according the TASC II classification: a single-center experienceSebastian Sixt, A Rastan, U Beschorner, et al.
The New England Journal of Medicine|June 23, 2001
Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofibanC P Cannon, W S Weintraub, L A Demopoulos, et al.
The New England Journal of Medicine|June 23, 2001
Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularizationE J Topol, D J Moliterno, H C Herrmann, et al.
Pageof 14

Showing results (131-140 of 136) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 136 results.
Journal of the American College of Cardiology|June 23, 2001
Long-term mortality benefit with abciximab in patients undergoing percutaneous coronary interventionK M Anderson, R M Califf, G W Stone, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 14, 1997
Dysregulation of monocytic nuclear factor-kappa B by oxidized low-density lipoproteinK Brand, T Eisele, U Kreusel, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|July 16, 2008
Long term outcome after balloon angioplasty and stenting of subclavian artery obstruction: a single centre experienceS Sixt, A Rastan, U Schwarzwälder, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|August 26, 2010
Acute and long-term outcome of Silverhawk assisted atherectomy for femoro-popliteal lesions according the TASC II classification: a single-center experienceSebastian Sixt, A Rastan, U Beschorner, et al.
The New England Journal of Medicine|June 23, 2001
Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofibanC P Cannon, W S Weintraub, L A Demopoulos, et al.
The New England Journal of Medicine|June 23, 2001
Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularizationE J Topol, D J Moliterno, H C Herrmann, et al.
Pageof 14